PMID: 2108128Apr 1, 1990Paper

Bacteriophage-enhanced sporulation: comparison of spore-converting bacteriophages PMB12 and SP10

Journal of Bacteriology
T H Silver-Mysliwiec, M G Bramucci

Abstract

The previously characterized bacteriophage SP10 enhanced the frequency of wild-type sporulation by Bacillus subtilis W23 and 3-13. Comparison of SP10 with the spore-converting bacteriophage PMB12 indicated that both bacteriophages significantly increased the sporulation frequency of an oligosporogenic mutant that contained spo0J::Tn917 omega HU261. SP10 and PMB12 caused wild-type bacteria to sporulate in a liquid medium that initially contained enough glucose to inhibit the sporulation and expression of alpha-amylase by uninfected bacteria. SP10 also induced the expression of alpha-amylase in the presence of glucose, whereas PMB12 had no detectable effect. These observations were consistent with the conclusion that SP10 is a spore-converting bacteriophage and that SP10 and PMB12 relieve glucose-mediated catabolite repression of sporulation by different mechanisms.

References

Nov 1, 1979·Canadian Journal of Microbiology·I Takahashi
Sep 1, 1978·Journal of Virology·K M KegginsP S Lovett
Sep 1, 1975·Bacteriological Reviews·H E Hemphill, H R Whiteley
Oct 1, 1975·Journal of Bacteriology·P S Lovett, M G Bramucci
Jan 1, 1986·Annual Review of Genetics·R LosickP J Piggot
Dec 1, 1987·Journal of Bacteriology·W L Nicholson, G H Chambliss
Sep 1, 1967·Journal of Bacteriology·K F Bott, G A Wilson
Mar 1, 1981·Journal of Bacteriology·D M Kinney, M G Bramucci
Jan 1, 1962·Journal of Bacteriology·C B THORNE

❮ Previous
Next ❯

Citations

Aug 12, 2014·Bacteriophage·Katherine R HargreavesMartha Rj Clokie
Apr 25, 2013·Virulence·Louis-Charles Fortier, Ognjen Sekulovic
Mar 7, 2008·Microbial Ecology·Kurt E WilliamsonK Eric Wommack
Dec 17, 2009·Applied and Environmental Microbiology·Jennifer MobberleyJ H Paul
Dec 22, 2020·The ISME Journal·Anna DragošÁkos T Kovács

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.